National Hispanic Science Network on Drug Abuse (NHSN) 2024 Conference Administrative Supplement
Project Number3R13DA026647-15S1
Former Number5R13DA026647-15
Contact PI/Project LeaderMOLINA, PATRICIA E.
Awardee OrganizationLSU HEALTH SCIENCES CENTER
Description
Abstract Text
2024 NHSN Conference Administrative Supplement Abstract
The purpose of this proposal is to request funding available through an administrative supplement for the National
Hispanic Science Network (NHSN) Annual Conference grant (R13 DA026647). The NHSN is dedicated to
improving health equity of Hispanics by increasing the amount, quality, and dissemination of interdisciplinary
translational research and fostering the development, advancement, and promotion of future Hispanic scientists
and leaders. The NHSN conference assembles members of the global research community focused on different
aspects of substance use disorder including epidemiology, toxicology, environmental health, intervention
science, psychology, sociology, health policy, and neurobiology as it pertains to Hispanic populations. The NHSN
conference is unique in that it serves as a forum for transdisciplinary scientific discourse spanning from basic
neuroscience to implementation science and policy. The NHSN conference serves as a venue for mentoring,
networking, and professional development of scientists underrepresented in their respective disciplines. The
2024 conference will serve as a unique venue for transdisciplinary and interprofessional scientific discussions
on strategies towards minimizing the impact of substance use disorders and their comorbidities on health
disparities in Hispanics and other underrepresented minorities. In addition, the conference will feature a session
dedicated to women’s health. We will continue to foster recruitment, retention, development, and advancement
of Hispanic scientists to promote future leaders in substance use disorder research and related areas. The
conference is an opportunity for trainees of diverse gender, ethnicity, discipline, and geographic location to come
together and participate in a multidisciplinary scientific meeting, establish peer support groups, and develop
professional relationships that provide venues for innovative developments in the field.
Public Health Relevance Statement
2024 NHSN Conference Administrative Supplement Project Narrative
Hispanics constitute the largest racial/ethnic underrepresented group in the United States and are
disproportionately impacted by substance use disorder, such as drug types, alcohol, tobacco, and more. There
is a pressing need to study the biological, individual, familial, community, legal, and contextual factors that
differentially affect substance use, its consequences, and the use of treatment services in Hispanic populations
through interdisciplinary and translational approaches. The proposed annual NHSN conference will continue to
serve as the premier venue for transdisciplinary, interdisciplinary, and interprofessional scientific discussions on
strategies to minimize the impact of substance use disorder on health disparities in Hispanics and other
underrepresented groups.
No Sub Projects information available for 3R13DA026647-15S1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3R13DA026647-15S1
Patents
No Patents information available for 3R13DA026647-15S1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3R13DA026647-15S1
Clinical Studies
No Clinical Studies information available for 3R13DA026647-15S1
News and More
Related News Releases
No news release information available for 3R13DA026647-15S1
History
No Historical information available for 3R13DA026647-15S1
Similar Projects
No Similar Projects information available for 3R13DA026647-15S1